-
From Sequencing to Treatment: The Role of Comprehensive Genome Profiling, Molecular Tumor Boards in Advanced-Stage NSCLC
Citing data from the FPG500 program, Drs. Antonio Vitale and Emilio Bria write that integrating genome profiling and molecular tumor boards into daily practice is feasible and yields measurable survival benefits for patients with actionable molecular alterations.
More Recent News
-
Under Therapeutic Pressure: ELCC Session Highlights How Tumor Switching is Reshaping the Treatment Landscape
Experts emphasize the need for multidisciplinary approaches, personalized therapies, and strategies to address intratumor heterogeneity.
-
Tobacco Endgame: A Critical Frontier for Lung Cancer Prevention and Equity
Drs. Babalola Faseru and Carolyn Dresler outline strategies to shift the paradigm from tobacco control to tobacco elimination, including expanded cessation and early-detection infrastructure.